Digital application to improve quality of life for young cancer patients
Efficacy Study on Quality of Life Criteria of a Digital Application on Any Cellphone (OnKO-Tips&Tricks) Allowing Daily Follow-ups, Implementation of an ETP Program and a Direct Link With the Nurse Coordinator of Units Specifically Dealing With Adolescents and Young Adults Diagnosed With Cancer
NA · University Hospital, Strasbourg, France · NCT05350631
This study tests whether a digital app can help young cancer patients aged 15-25 feel better and improve their quality of life during and after treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 15 Years to 25 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France (other) |
| Drugs / interventions | chemotherapy |
| Locations | 10 sites (Lyon and 9 other locations) |
| Trial ID | NCT05350631 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the OnKO-Tips&Tricks digital application designed for adolescents and young adults aged 15-25 diagnosed with cancer. The application aims to provide psychosocial support and resources tailored to the unique needs of this age group during and after their cancer treatment. Nurse Coordinators will play a key role in assessing patient needs and facilitating care coordination. Participants will be followed for 12 months to assess the impact of the application on their quality of life.
Who should consider this trial
Good fit: Ideal candidates are adolescents and young adults aged 15-25 who have been diagnosed with solid or blood cancers within the last month or have experienced a relapse more than five years after initial treatment.
Not a fit: Patients who are unable to understand or communicate in French or those who are deprived of liberty may not benefit from this study.
Why it matters
Potential benefit: If successful, this application could significantly enhance the quality of life and support for young cancer patients during their treatment journey.
How similar studies have performed: While there is ongoing interest in digital health applications for cancer care, this specific approach targeting adolescents and young adults is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient age ≥ 15 years and ≤ 25 years * Diagnosed with solid or blood cancers less than 1 month old or patient with relapsed cancer more than 5 years after completion of initial treatment * Follow-up at one of the participating study centers * Informed and signed consent from the patient and, if the subject is a minor, from the holders of parental authority * Inclusion in the study at the latest at the time of initiation of chemotherapy or radiotherapy * Patient agrees to 12-month post-inclusion follow-up * Patient agreeing to complete all study questionnaires * Patient with a cellphone capable of downloading the app (developed for all types of cellphones) * Affiliated to a social health insurance plan Exclusion Criteria: * Patient deprived of liberty by a judicial or administrative decision * Patient with protected person status * Patient who does not understand, speak or write French * Patient unable to understand the follow-up protocol according to the investigating physician or the IDEC of the AJA unit * Patient with a scheduled hospitalization of at least 5 weeks during study participation
Where this trial is running
Lyon and 9 other locations
- Institut d'Hématologie et d'Oncologie Pédiatrique — Lyon, France (RECRUITING)
- Assistance Publique - Hôpitaux de Marseille — Marseille, France (NOT_YET_RECRUITING)
- Hôpital enfant-adolescent — Nantes, France (RECRUITING)
- CHU de Nice Hôpital Archet 2 — Nice, France (RECRUITING)
- CHU Reims - Hôpital Maison Blanche — Reims, France (RECRUITING)
- CHU Rennes Hôpital Sud — Rennes, France (RECRUITING)
- Institut de Cancérologie de l'Ouest — Saint-Herblain, France (NOT_YET_RECRUITING)
- Hôpitaux Universitaires de Strasbourg — Strasbourg, France (RECRUITING)
- Institut de Cancerologie Strasbourg Europe — Strasbourg, France (RECRUITING)
- Institut Gustave Roussy — Villejuif, France (NOT_YET_RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Adolescents population, Young adults population